Physicians' Academy for Cardiovascular Education

Stroke

No reduction of recurrent stroke with DOAC after embolic stroke of undetermined source

Literature - June 12, 2019 - Diener H-C, et al. - N Engl J Med 2019

Dabigatran therapy did not result in a reduction of recurrent strokes compared to aspirin use after embolic stroke of undetermined source, whereas risk of nonmajor bleeding was higher with dabigatran.

High residual inflammatory risk associated with adverse clinical outcomes in patients undergoing PCI with low LDL-c

Literature - June 7, 2019 - Guedeney P et al. - JACC 2019
A single-center prospective PCI-registry showed an independent association of high residual inflammatory risk and adverse clinical outcomes in patients undergoing PCI with LDL-c ≤70 mg/dL at baseline.

A single-center prospective PCI-registry showed an independent association of high residual inflammatory risk and adverse clinical outcomes in patients undergoing PCI with LDL-c ≤70 mg/dL at baseline.

Uninterrupted treatment with NOAC as alternative to VKA for ablation of AF

Literature - June 5, 2019 - Hohnloser SH et al. - Eur Heart J 2019

The exploratory ELIMINATE-AF study demonstrated that uninterrupted treatment with edoxaban represents an alternative to continuous VKA in patients undergoing catheter ablation of AF.

Factor Xa inhibitor reduces stroke risk in patients with HFrEF, sinus rhythm and CAD

News - May 25, 2019
A subanalysis of the COMMANDER-HF trial demonstrated that low dose rivaroxaban decreased stroke/TIA risk in patients with HFrEF, sinus rhythm and CAD without increase in major bleeding.

ESC HF 2019 A subanalysis of the COMMANDER-HF trial demonstrated that low dose rivaroxaban decreased stroke/TIA risk in patients with HFrEF, sinus rhythm and CAD without increase in major bleeding.

Increase in hs-troponin I associated with higher risk of CVD in individuals without CVD history

Literature - May 14, 2019 - Jia X, et al. - Circulation 2019

In individuals without CVD history in the ARIC study, increase in troponin I, measured by a high sensitivity assay, was associated with ASCVD, global CVD, CHD, stroke, HF hospitalization, and all-cause mortality.

Total antibiotic exposure time in different life-stages associated with higher CVD risk in later life

Literature - May 9, 2019 - Heianza Y et al. - Eur Heart J 2019
In women, longer total exposure to antibiotics in middle- and late adulthood was significantly associated with risk of CVD in later life, and antibiotic use in middle adulthood with risk of CHD but not of stroke.

In women, longer total exposure to antibiotics in middle- and late adulthood was significantly associated with risk of CVD in later life, and antibiotic use in middle adulthood with risk of CHD but not of stroke.

FDA expands indication for PCSK9 inhibitor to prevent major CV events in adults with CVD

News - May 6, 2019

The FDA has approved alirocumab to reduce the risk of MI, stroke, and unstable angina requiring hospitalization in adults with established CVD, based on ODYSSEY OUTCOMES data.

Many patients initiating statin therapy show sub-optimal LDL-c lowering, resulting in higher CVD risk

Literature - Apr. 29, 2019 - Akyea RK et al. - Heart 2019

In a primary care patient cohort, >50% of patients initiating statin therapy did not show optimal LDL-c lowering, which significantly increased their risk of future CVD events.

Low LDL-c and TG levels associated with risk of hemorrhagic stroke in women

Literature - Apr. 18, 2019 - Rist PM et al., - Neurology 2019

In a large, prospective cohort of women, those with LDL-c <70 mg/dL and potentially those with LDL-c ≥160 mg/dL and those with low TG, showed a higher risk of hemorrhagic stroke.

Higher consumption of dietary cholesterol or eggs linked to increased risk of incident CVD and mortality

Literature - Apr. 4, 2019 - Zhong VW et al. - JAMA 2019
Among US adults, higher consumption of dietary cholesterol or eggs was significantly associated with higher risk of incident CVD and all-cause mortality in a dose-response manner.

Among US adults, higher consumption of dietary cholesterol or eggs was significantly associated with higher risk of incident CVD and all-cause mortality in a dose-response manner.

No reduction in mortality and CV outcomes with catheter ablation in AF

Literature - Apr. 2, 2019 - Packer DL, et al. - JAMA 2019

In the CABANA trial, catheter ablation did not result in a reduction of death, disabling stroke, serious bleeding or cardiac arrest in symptomatic AF patients compared to drug therapy.

DOACs may reduce thromboembolic events in patients with mitral stenosis and AF

Literature - Mar. 13, 2019 - Kim JY et al. - JACC 2019

In an exploratory analysis of insurance data, DOAC use reduced stroke or systemic embolism in patients with mitral stenosis and AF compared to warfarin.